Adjuvant endocrine therapy: A cornerstone of systemic therapy for hormone receptor-positive breast cancer
Adjuvant endocrine therapy remains a cornerstone of systemic therapy for hormone receptor-positive breast cancer. Dr Joyce Habib explains how there has been shift in the choice and duration of adjuvant endocrine therapy in pre and postmenopausal patients.
Read More